We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA WARNS N.J. DRUGMAKER FOR cGMP VIOLATIONS
FDA WARNS N.J. DRUGMAKER FOR cGMP VIOLATIONS
June 7, 2004
Tri-Med Laboratories has been cited by the FDA for a slew of cGMP violations at its Somerset, N.J., plant, where it manufacturers cough and cold syrups and other products.